Shares of Icosavax, Inc. ICVX rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.
Icosavax also reported topline interim Phase 2 results for combination VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults.
Icosavax shares gained 44.8% to $15.19 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Bruush Oral Care Inc. BRSH shares rose 76.8% to $0.2882 in pre-market trading after gaining over 5% on Monday.
- Connect Biopharma Holdings Limited CNTB rose 32.2% to $1.19 in pre-market trading. Connect Biopharma will present top-line data from the global Phase 2b trial evaluating rademikibart’s efficacy and safety in patients with moderate-to-severe asthma on Dec. 12, 2023.
- Kaival Brands Innovations Group, Inc. KAVL shares rose 28% to $0.3159 in pre-market trading. Kaival Brands recently appointed James W. Dobbins as General Counsel.
- IN8bio, Inc.INAB gained 25.8% to $1.61 in pre-market trading after the company announced updated data from its Phase 1 investigator-sponsored trial of INB-100 in patients with hematologic malignancies.
- Avenue Therapeutics, Inc. ATXI gained 21.2% to $0.1649 in pre-market trading after falling 11% on Monday.
- Hanryu Holdings, Inc. HRYU shares surged 16% to $0.73 in pre-market trading after jumping 40% on Monday.
- TeraWulf Inc. WULF shares gained 12% to $1.59 in pre-market trading after falling 22% on Monday.
- Tenax Therapeutics, Inc. TENX shares climbed 10.6% to $0.2999 in pre-market trading.
- Blue Bird Corporation BLBD shares rose 7.3% to $23.40 in pre-market trading after the company reported better-than-expected financial results for its fourth quarter and increased its FY24 revenue forecast.
Losers
- Harbor Custom Development, Inc. HCDI shares fell 18.6% to $0.5538 in pre-market trading. Harbor Custom Development voluntarily filed for protection under Chapter 11 Bankruptcy.
- SRIVARU Holding Limited SVMH fell 17.3% to $0.5958 in pre-market trading after jumping 20% on Monday.
- Achieve Life Sciences, Inc. ACHV shares fell 21.1% to $4.30 in pre-market trading. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline.
- Assure Holdings Corp. IONM shares fell 13.4% to $0.3740 in pre-market trading after climbing over 23% on Monday.
- Clearmind Medicine Inc. CMND fell 13.2% to $2.64 in pre-market trading. Clearmind Medicine filed for mixed shelf of up to $50 million.
- Exicure, Inc. XCUR shares fell 12.2% to $0.5480 in pre-market trading after jumping over 20% on Monday.
- Assembly Biosciences, Inc. ASMB fell 11.1% to $0.6750 in pre-market.
- Onconova Therapeutics, Inc. ONTX shares fell 11% to $0.7034 in pre-market trading after gaining 23% on Monday.
- Hempacco Co., Inc. HPCO shares fell 10.8% to $0.3606 in pre-market trading.
- Oracle Corporation ORCL fell 8.5% to $105.40 in pre-market trading. Oracle reported upbeat earnings for its second quarter, while sales missed estimates.
Now Read This: Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in